"Chemokine CXCL10" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is induced by GAMMA-INTERFERON and is chemotactic for MONOCYTES and T-LYMPHOCYTES. It has specificity for the CXCR3 RECEPTOR.
| Descriptor ID |
D054357
|
| MeSH Number(s) |
D12.644.276.374.200.120.500 D12.776.467.374.200.120.500 D23.125.300.120.500 D23.469.200.120.500 D23.529.374.200.120.500
|
| Concept/Terms |
Chemokine CXCL10- Chemokine CXCL10
- CXCL10, Chemokine
- Cytokine IP-10 Protein
- Cytokine IP 10 Protein
- IP-10 Protein, Cytokine
- Interferon-Inducible Protein 10
- Interferon Inducible Protein 10
- CXC Chemokine IP-10
- CXC Chemokine IP 10
- Chemokine IP-10, CXC
- Small Inducible Cytokine B10
- IFN-gamma-Inducible Protein, 10 kDa
- IFN gamma Inducible Protein, 10 kDa
- CXCL10 Chemokine
- Chemokine, CXCL10
- gammaIP-10 Protein
- gammaIP 10 Protein
- Chemokine (C-X-C Motif) Ligand 10
- Interferon-gamma-Inducible Protein of 10 kDa
- Interferon gamma Inducible Protein of 10 kDa
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL10".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL10".
This graph shows the total number of publications written about "Chemokine CXCL10" by people in this website by year, and whether "Chemokine CXCL10" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL10" by people in Profiles.
-
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2021 06; 73(6):1005-1013.
-
LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway. Apoptosis. 2018 12; 23(11-12):651-666.
-
The Living Scar--Cardiac Fibroblasts and the Injured Heart. Trends Mol Med. 2016 Feb; 22(2):99-114.
-
FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain. J Immunol. 2015 Dec 15; 195(12):5551-60.
-
Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy. PLoS One. 2015; 10(7):e0133236.
-
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J Clin Invest. 2014 Aug; 124(8):3352-63.
-
The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment. PLoS One. 2013; 8(11):e79751.
-
Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care. 2013 Jul; 36(7):2054-61.
-
Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma. Arthritis Res Ther. 2013; 15(6):R188.
-
Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator. J Neuroinflammation. 2012 Oct 18; 9:239.